Privia Health Financials
PRVA Stock | USD 23.34 0.05 0.21% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Debt Equity Ratio | 0.0084 | 0.0088 |
|
| |||||
Current Ratio | 1.34 | 1.8587 |
|
|
The essential information of the day-to-day investment outlook for Privia Health includes many different criteria found on its balance sheet. An individual investor should monitor Privia Health's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Privia Health.
Net Income |
|
Privia | Select Account or Indicator |
Please note, the presentation of Privia Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Privia Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Privia Health's management manipulating its earnings.
Privia Health Stock Summary
Privia Health competes with Certara, HealthStream, National Research, HealthEquity, and Evolent Health. Privia Health Group, Inc. operates as a national physician-enablement company in the United States. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC. Privia Health operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 810 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US74276R1023 |
CUSIP | 74276R102 |
Location | Virginia; U.S.A |
Business Address | 950 North Glebe |
Sector | Health Care Providers & Services |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.priviahealth.com |
Phone | 571 366 8850 |
Currency | USD - US Dollar |
Privia Health Key Financial Ratios
Return On Equity | 0.0264 | ||||
Profit Margin | 0.01 % | ||||
Operating Margin | 0.01 % | ||||
Price To Sales | 1.62 X | ||||
Revenue | 1.74 B |
Privia Health Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Other Current Liab | 140.8M | 183.7M | 251.5M | 376.0M | 436.8M | 232.1M | |
Other Liab | 7.8M | 5.6M | 3M | 1M | 900K | 855K | |
Net Tangible Assets | (15.1M) | 22.1M | 239.2M | 314.8M | 362.0M | 380.1M | |
Retained Earnings | (19.9M) | (208.1M) | (216.7M) | (193.6M) | (179.2M) | (188.2M) | |
Accounts Payable | 5.2M | 3.0M | 6.7M | 7.9M | 9.8M | 5.9M | |
Other Assets | 9.7M | 9.4M | 37.9M | 45.1M | 51.8M | 54.4M | |
Net Receivables | 99.1M | 117.4M | 189.6M | 290.8M | 316.2M | 182.5M | |
Total Current Assets | 190.1M | 446.7M | 552.0M | 700.8M | 834.8M | 466.6M | |
Common Stock | 960K | 1.1M | 1.1M | 1.2M | 1.2M | 1.2M | |
Total Assets | 329.0M | 686.4M | 792.8M | 999.9M | 1.1B | 772.6M | |
Net Debt | (51.0M) | (274.1M) | (336.5M) | (381.2M) | (485.6M) | (461.3M) | |
Cash | 84.6M | 320.6M | 348.0M | 389.5M | 491.1M | 308.1M | |
Other Current Assets | 6.3M | 17.4M | 14.4M | 20.5M | 27.5M | 16.8M | |
Total Liab | 185.3M | 236.2M | 273.8M | 392.5M | 452.3M | 312.2M | |
Net Invested Capital | 180.4M | 459.4M | 499.1M | 561.4M | 635.2M | 456.3M | |
Capital Stock | 960K | 1.1M | 1.1M | 1.2M | 1.2M | 1.2M | |
Net Working Capital | 43.1M | 256.2M | 287.7M | 313.9M | 385.7M | 238.5M | |
Short Term Debt | 875K | 3.8M | 6.0M | 3.0M | 2.6M | 3.6M | |
Intangible Assets | 6.0M | 59.7M | 57.4M | 107.6M | 109.8M | 63.6M |
Privia Health Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Tax Provision | (7.4M) | (27.9M) | (6.5M) | (7.4M) | 10.8M | 11.4M | |
Net Interest Income | (1.9M) | (1.1M) | 542K | 6.7M | 10.9M | 11.4M | |
Interest Expense | 1.9M | 1.1M | 542K | 8.4M | 7.5M | 7.9M | |
Total Revenue | 817.1M | 966.2M | 1.4B | 1.7B | 1.7B | 1.3B | |
Gross Profit | 82.6M | 63.7M | 134.8M | 161.5M | 176.9M | 117.0M | |
Operating Income | 25.4M | (217.4M) | (19.1M) | 20.6M | 17.0M | 17.8M | |
Ebit | 25.4M | (217.4M) | (19.1M) | 20.6M | 17.0M | 17.8M | |
Ebitda | 27.2M | (215.0M) | (14.6M) | 27.2M | 24.3M | 25.5M | |
Cost Of Revenue | 734.5M | 902.6M | 1.2B | 1.5B | 1.6B | 1.1B | |
Income Before Tax | 23.5M | (218.5M) | (18.6M) | 29.0M | 27.9M | 29.3M | |
Net Income | 31.2M | (190.6M) | (12.1M) | 23.1M | 14.4M | 15.1M | |
Income Tax Expense | (7.4M) | (27.9M) | (6.5M) | 8.0M | 10.8M | 11.4M | |
Minority Interest | (3.1M) | 2.4M | 3.5M | 2.5M | (2.7M) | (2.5M) |
Privia Health Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Investments | (380K) | (32.8M) | (104K) | (38.0M) | (12.0M) | (12.6M) | |
Change In Cash | 37.7M | 235.9M | 27.4M | 41.5M | 101.6M | 74.2M | |
Free Cash Flow | 38.5M | 54.5M | 47.1M | 80.7M | 109.3M | 55.6M | |
Depreciation | 1.8M | 2.5M | 4.6M | 6.5M | 7.3M | 4.0M | |
Other Non Cash Items | 134K | 157K | 687K | (2.1M) | 19.5M | 20.4M | |
Capital Expenditures | 5.7M | 380K | 547K | 104K | 113K | 0.0 | |
Net Income | 30.9M | (190.6M) | (12.1M) | 23.1M | 17.0M | 17.9M | |
End Period Cash Flow | 84.6M | 320.6M | 348.0M | 389.5M | 491.1M | 270.3M | |
Change To Netincome | 624K | (7.7M) | 222.7M | 60.4M | 69.4M | 60.8M |
Privia Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Privia Health's current stock value. Our valuation model uses many indicators to compare Privia Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Privia Health competition to find correlations between indicators driving Privia Health's intrinsic value. More Info.Privia Health Group is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about 0.38 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Privia Health Group is roughly 2.67 . At present, Privia Health's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Privia Health's earnings, one of the primary drivers of an investment's value.Privia Health Group Systematic Risk
Privia Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Privia Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Privia Health Group correlated with the market. If Beta is less than 0 Privia Health generally moves in the opposite direction as compared to the market. If Privia Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Privia Health Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Privia Health is generally in the same direction as the market. If Beta > 1 Privia Health moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Privia Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Privia Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Privia Health growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Privia Health March 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Privia Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Privia Health Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Privia Health Group based on widely used predictive technical indicators. In general, we focus on analyzing Privia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Privia Health's daily price indicators and compare them against related drivers.
Downside Deviation | 2.18 | |||
Information Ratio | 0.1156 | |||
Maximum Drawdown | 12.06 | |||
Value At Risk | (2.95) | |||
Potential Upside | 3.1 |
Complementary Tools for Privia Stock analysis
When running Privia Health's price analysis, check to measure Privia Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Privia Health is operating at the current time. Most of Privia Health's value examination focuses on studying past and present price action to predict the probability of Privia Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Privia Health's price. Additionally, you may evaluate how the addition of Privia Health to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Stocks Directory Find actively traded stocks across global markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |